Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

K-mer Workshop for Biodiversity Genomics

K-mers are a fundamental and versatile tool in bioinformatics, offering powerful solutions to various challenges in genomics. This workshop is designed to equip researchers with [...]

Multiomics in Metabolic Disease

Genetic and biological factors significantly influence the risk of metabolic disorders such as obesity, type 2 diabetes, and dyslipidemia. Advances in ‘omics’ technologies—genomics, epigenomics, transcriptomics, [...]

Curating the Clinical Genome Conference

This event will explore best practices for the clinical application of genomic data, focusing on variant interpretation, clinical utility, and the development of consensus-curated knowledge. [...]

AI x BIO Conference

This event will explore best practices for the clinical application of genomic data, focusing on variant interpretation, clinical utility, and the development of consensus-curated knowledge. [...]

Mitochondrial Medicine – Therapeutic Development

Mitochondrial disorders are now recognised as a significant cause of inherited disease. Progress toward new treatments relies on strong collaboration between clinicians, lab-based researchers, and [...]

Go to Top